Court Admissions: Licensed in Kansas and admitted to practice by the Supreme Court of Kansas and US District Court for the District of Kansas

Member of: American Trial Lawyers Association, American Bar Association, Kansas Trial Lawyers Association, Kansas Trial Lawyers Board of Governors, Kansas Bar Association, Wichita Bar Association, Wichita Women's Bar Association, Charter Member of American Association of Legal Nurse Consultants.

Elizabeth "Liz" Dudley, R.N., J.D.  Appointed to National Bextra/Celebrex Plaintiffs committees.

On September 6th, 2005, all of the individual lawsuits filed in federal court involving Pfizer's cox-2 inhibitors [Bextra or Celebrex] causing various personal injuries were consolidated for discovery purposes in front of the Honorable Charles R. Breyer in the Northern District of California, San Francisco. The Hutton firm, with Mark Hutton as lead counsel, and Liz Dudley, have already filed many cases against both Merck [regarding Vioxx cardiovascular injuries] and Pfizer [Bextra/Celebrex induced cardiovascular and Stevens-Johnson skin injuries].  As a result, the Plaintiffs Steering Committee for the Bextra/Celebrex Mass Tort Litigation have appointed Liz Dudley to the following committees:  Science & Expert Committee and the Discovery Committee.  The plaintiff's committees are currently reviewing documents, contacting various scientific and medical experts and preparing to take depositions of Pfizer's key witnesses.  The committees plan to have a dynamite generic trial package for other plaintiff's attorneys to use when the cases are transferred back to their original jurisdiction for trials.  Additionally, a few select trials will be held by the Honorable Judge Breyer in California sometime in 2007.  Bextra was withdrawn from the market on April 7th, 2005.  However, Celebrex remains on the market.